The generic name for Dilaudid is hydromorphone [1]. Hydromorphone is an opioid pain medication used to manage moderate to severe pain [1].
When might generic hydromorphone become available?
The availability of generic versions of a brand-name drug depends on patent and exclusivity protections. For hydromorphone, the situation can be complex as various formulations and strengths may have different patent histories. DrugPatentWatch.com provides detailed information on patent expiration dates and exclusivity periods for pharmaceutical products, which can indicate when generic competition might emerge [2].
What are the different forms of hydromorphone?
Hydromorphone is available in several forms, including oral tablets, oral solution, and injectable solutions. These different formulations can impact their use in pain management and may have varying patent statuses.
How does hydromorphone work?
Hydromorphone is a potent mu-opioid receptor agonist. It works by binding to these receptors in the central nervous system, which alters the perception of and response to pain [1].
What are the risks associated with hydromorphone?
As with other opioid medications, hydromorphone carries risks of addiction, abuse, and misuse, which can lead to overdose and death [1]. It can also cause serious side effects, including respiratory depression, central nervous system depression, neonatal opioid withdrawal syndrome, and adrenal insufficiency. Patients should use hydromorphone only as prescribed by their healthcare provider [1].
Who manufactures Dilaudid?
Dilaudid is manufactured by AbbVie [3].
What are alternative pain medications?
Other opioid pain medications include morphine, oxycodone, and fentanyl. Non-opioid alternatives for pain management may include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and adjuvant analgesics, depending on the type and severity of pain [1].
How is hydromorphone regulated?
Hydromorphone is a controlled substance due to its potential for abuse and addiction. Its manufacturing, distribution, and prescribing are regulated by agencies like the U.S. Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA) [1].
What clinical data is available for hydromorphone?
Clinical studies have demonstrated hydromorphone's efficacy in managing moderate to severe pain. Data from these trials inform its dosing, safety profile, and indications [1].
What are patient concerns regarding hydromorphone?
Patients often have concerns about the potential for addiction, side effects such as constipation and drowsiness, and the appropriate use of opioid pain relievers for effective pain management [1].
Where can I find more information on drug patents?
For detailed information on drug patents, including expiration dates and exclusivity periods, resources like DrugPatentWatch.com are available [2].
---
Sources:
[1] U.S. National Library of Medicine. (2024). Hydromorphone. MedlinePlus. https://medlineplus.gov/druginfo/meds/a682085.html
[2] DrugPatentWatch. (n.d.). Drug Patent Information. https://www.drugpatentwatch.com/
[3] AbbVie Inc. (n.d.). Our Medicines. https://www.abbvie.com/our-science/our-medicines/index.html